21 CFR Subpart C
Abbreviated Applications
June 25, 2020
§
314.94
Content and format of an ANDA
§
314.95
Notice of certification of invalidity, unenforceability, or noninfringement of a patent
§
314.96
Amendments to an unapproved ANDA
§
314.92
Drug products for which abbreviated applications may be submitted
§
314.93
Petition to request a change from a listed drug
§
314.97
Supplements and other changes to an approved ANDA
§
314.98
Postmarketing reports
§
314.99
Other responsibilities of an applicant of an ANDA